Mark H. Einstein

Mark H. Einstein, MD, MS, FACS, FACOG is Professor and Chair of Obstetrics, Gynecology and Women?s Health at Rutgers New Jersey Medical School. Dr. Einstein is a Gynecologic Oncologist who is an expert at identification and treatment of gynecologic malignancies. His primary research interests focus on the pathogenesis, therapy, and prevention of lower anogenital tract and gynecologic cancers. He leads numerous clinical efforts identifying unique targets and biomarkers for clinical risk of malignant transformation. He is also testing many novel drugs for cancer treatment. He has been an active leader for management guidelines and translating clinical trial and translational data for such organizations as the World Health Organization (WHO), American Cancer Society (ACS), Society of Gynecologic Oncology (SGO), American College of Obstetrics and Gynecology (ACOG), and Society of Lower Genital Tract Disease (ASCCP). He serves on the Boards for SGO and the ASCCP. He has served on numerous committees and leadership for the National Cancer Institute (NCI)-funded NRG Oncology group and AIDS Malignancy Consortium (AMC). Currently, he serves as a principal investigator on many multi- institutional clinical trials for gynecologic cancers in the US and Internationally. He has been funded for his research efforts by a number of organizations including the NCI, ACS, Foundation for Women?s Cancers, and others.